Eugene cancer drug company wins angel funding

Eugene cancer drug company wins angel funding

Eugene-based Cascade Prodrug won the $200,000 investment prize in the fourth annual Willamette Angel Conference.

“We think it’s a great investment opportunity and a high-potential Oregon company,” said Skip Rung, president of ONAMI, a 2012 Willamette Angel Conference investor. ONAMI is one of Oregon’s Signature Research Centers, a collaboration between Oregon universities, Pacific Northwest National Laboratory, industry and the investment community .

Now in its fourth year, the annual Willamette Angel Conference aims to match investors with startup and early stage companies. In those four years, the conference has invested more than $700,000 in regional early stage companies, said Dave Hauser, president of the Eugene Area Chamber of Commerce.

Read more at The Register-Guard.
{biztweet}cascade prodrug{/biztweet}